![Toru Sato](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Oorsprong van het eerstegraads netwerk van Toru Sato
Entiteit | Type entiteit | Industrie | |
---|---|---|---|
Sonire Therapeutics, Inc. (TY)
![]() Sonire Therapeutics, Inc. (TY) Medical SpecialtiesHealth Technology Sonire Therapeutics, Inc. (TY) is a company based in Tokyo, Japan. The Japanese company specializes in developing a next-generation ultrasonic guide ultrasonic ultrasonic treatment device using acoustic engineering (ultrasonic) technology created from academia, which conducts cutting-edge research. The device uses high-intensity focused ultrasound (HIFU) and is designed to be used under ultrasonic guidance. The company was founded in 2020 and the CEO is Toru Sato.
2
| Holding Company | Medical Specialties | 2 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Toru Sato via zijn persoonlijke netwerk
Onderneming | Sector | Gelieerde personen | Hoofdpost |
---|---|---|---|
Fast Track Initiative, Inc.
![]() Fast Track Initiative, Inc. Investment ManagersFinance Fast Track Initiative, Inc. (FTI) is a Venture Capital firm, a subsidiary of Life Science Management, Inc. founded in 2004 by Koichi Ashida and Hiromichi Kimura. Fast Track Initiative, Inc. is headquartered in Tokyo with additional office in the Unites States. | Investment Managers | Private Equity Analyst | |
Rin Institute, Inc.
![]() Rin Institute, Inc. Pharmaceuticals: MajorHealth Technology Rin Institute, Inc. is a company based in Tokyo, Japan that was founded in 2016 by Kentaro Yoshimatsu. The Japanese company's website simply states that it is "just another WordPress site." | Pharmaceuticals: Major | Director/Board Member |
Statistieken
Internationaal
Japan | 3 |
Sectoraal
Finance | 2 |
Health Technology | 2 |
Operationeel
Director/Board Member | 3 |
Private Equity Analyst | 1 |
Chief Operating Officer | 1 |
Sterkste connecties
Insiders | |
---|---|
Hiroko Kimura | 3 |
Jun Okamoto | 1 |